Stocks to Buy | Strategic Bets, High Valuations: Amnish Aggarwal Breaks Down the Market Moves​ – ​Torrent Pharma’s Big Bet on JB Chemicals​ – News Air Insight

Spread the love



Amnish Aggarwal in an interview to ET Now said that as Torrent Pharma is looking to acquire a controlling stake in JB Chemicals from KKR, valuing the company at ₹25,689 crore, this translates to about 6.5 times EV to sales, making it an expensive deal. However, strategically, he believes it complements Torrent’s portfolio in the domestic branded generics space with well-known drugs like Rantac and Nicardia.

Amnish Aggarwal also highlighted that the acquisition strengthens Torrent’s position in the CDMO (Contract Development and Manufacturing Organization) segment, enabling it to scale operations both in India and globally. He sees it as a long-term strategic move rather than a near-term value driver.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *